Zimmer Biomet
989 hedge funds and large institutions have $27.3B invested in Zimmer Biomet in 2019 Q4 according to their latest regulatory filings, with 155 funds opening new positions, 303 increasing their positions, 326 reducing their positions, and 44 closing their positions.
252% more first-time investments, than exits
New positions opened: 155 | Existing positions closed: 44
156% more call options, than puts
Call options by funds: $94.8M | Put options by funds: $37.1M
10% more funds holding
Funds holding: 896 → 989 (+93)
9% more capital invested
Capital invested by funds: $25B → $27.3B (+$2.36B)
9% more funds holding in top 10
Funds holding in top 10: 23 → 25 (+2)
0.15% more ownership
Funds ownership: 91.31% → 91.46% (+0.15%)
7% less repeat investments, than reductions
Existing positions increased: 303 | Existing positions reduced: 326
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$182M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$110M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$86.8M |
| 4 |
Truist Financial
Charlotte,
North Carolina
|
+$68.3M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$58.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Causeway Capital Management
Los Angeles,
California
|
-$139M |
| 2 |
JP Morgan Chase
New York
|
-$112M |
| 3 |
Millennium Management
New York
|
-$110M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$96.9M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$78.2M |
ZBH Hedge Fund Activity: Q4 2019 in Review
989 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q4 2019, worth a combined $27.3B — up 9.5% from $25B a quarter earlier.
Buyers outnumbered sellers: 155 funds opened new ZBH positions and 44 closed out — a net gain of 111 holders — while 303 added to existing stakes and 326 trimmed.
The largest buyer was Amundi Asset Management US, adding an estimated $182M. The largest seller was Causeway Capital Management, exiting entirely with an estimated $139M sold.
- 989 institutional investors held Zimmer Biomet (ZBH) as of Q4 2019, up from 896 in Q3 2019.
- Funds reported $27.3B of Zimmer Biomet stock for Q4 2019, up 9.5% quarter-over-quarter.
- 155 funds opened new Zimmer Biomet positions in Q4 2019 and 44 closed out, a net change of +111 holders.
- The largest Zimmer Biomet buyer in Q4 2019 was Amundi Asset Management US, an estimated $182M added.
- The largest Zimmer Biomet seller in Q4 2019 was Causeway Capital Management, an estimated $139M sold.
Based on aggregated 13F filings for Q4 2019.